US Patent

US12447190 — Vasopressin premix systems and uses thereof

Formulation · Assigned to Baxter Healthcare SA · Expires 2044-09-27 · 18y remaining

Vulnerability score 43/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a system for intravenous administration of a premix vasopressin pharmaceutical formulation in a flexible container.

USPTO Abstract

Provided is a system comprising a flexible container for intravenous administration which comprises a premix vasopressin pharmaceutical formulation, and uses thereof.

Drugs covered by this patent

vasopressin (VASOPRESSIN)

Patent Metadata

Patent number: US12447190
Jurisdiction: US
Classification: Formulation
Expires: 2044-09-27
Drug substance claim: No
Drug product claim: Yes
Assignee: Baxter Healthcare SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.